Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong · Delayed Price · Currency is HKD

2.435

-0.125 (-4.88%)

Sep 18, 2026, 4:08 PM HKT

HKG:6955 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	624.41	784.82	726.32	618.13	515.96	158.7
Revenue Growth	-20.44%	8.05%	17.50%	19.80%	225.11%	-
Gross Profit	425.85	562.44	542.65	408.97	354.23	106.51
Operating Income	-76.91	32.72	61.08	-129.93	-342.53	-221.27
Net Income	-96.38	7.14	73.19	-119.38	-331.75	-225.42
Earnings Per Share	-0.16	0.01	0.14	-0.23	-0.67	-0.47
EPS Growth	-	-90.91%	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	573.58	747.63	726.32	618.13	515.96	158.7
Other Countries	-	37.19	-	-	-	-
Total	624.41	784.82	726.32	618.13	515.96	158.7

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,105	1,130	198.87	201.85	233.5	613.56
Total Debt	843.59	783.28	685.54	405.91	301.72	264.52
Net Cash (Debt)	261.87	347.13	-486.67	-204.06	-68.23	349.04
Net Cash Growth	-24.56%	-	-	-	-	-
Net Cash Per Share	0.44	0.60	-0.91	-0.40	-0.14	0.73

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	64.89	-117.94	-18.57	-201.84	-246.28
Capital Expenditures	-	-72.55	-66.6	-67.32	-81.29	-107.73
Free Cash Flow	-	-7.66	-184.53	-85.89	-283.13	-354.01
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	68.20%	71.66%	74.71%	66.16%	68.66%	67.12%
Operating Margin	-12.32%	4.17%	8.41%	-21.02%	-66.39%	-139.42%
Pretax Margin	-15.44%	0.91%	10.08%	-19.31%	-64.30%	-142.04%
Profit Margin	-15.43%	0.91%	10.08%	-19.31%	-64.30%	-142.04%
FCF Margin	-	-0.98%	-25.41%	-13.89%	-54.87%	-223.06%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	668.53	64.20	-	-	-
Forward PE	-	23.20	-	-	-	-
PS Ratio	2.10	6.09	6.47	11.59	17.29	-